Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05921539
Status:
RECRUITING
Last Update Posted:
2023-06-27
First Post:
2021-11-22
Brief Title:
Does Axillary Nerve and Inferior Capsule Release Add Extra Benefit in Treating Patients With Adhesive Capsulitis
Sponsor:
Taipei Veterans General Hospital Taiwan
Organization:
Taipei Veterans General Hospital Taiwan
Study Overview
Official Title:
Does Axillary Nerve and Inferior Capsule Release Add Extra Benefit to Steroid Hydrodilatation in Treating Patients With Adhesive Capsulitis
Status:
RECRUITING
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was conducted to compare the efficacy of hydrodilatation with steroid via posterior approach versus hydrodilatation with steroid with axillary nerve injection for treating patients with adhesive capsulitis
Detailed Description:
Adhesive capsulitis is a common cause of shoulder pain and the efficacy of most interventions is limited This study was conducted to compare the efficacy of rotator interval injection with steroid with that of steroid hydrodilatatoin for treating adhesive capsulitis
Design a prospective single-blinded randomized clinical trial
Patient and methods
Patients with adhesive capsulitis were enrolled and randomly allocated into group 1 ultrasound guided hydrodilatation with steroid via posterior approach and group 2 ultrasound guided hydrodilatation with steroid via posterior approach as well as axillary nerve injection The patients were evaluated before treatment and were reevaluated 0 6 and 12 weeks after the beginning of the treatment Outcomes measures included a pain scale visual analog scale range of motion and Shoulder Pain And Disability Index
Design a prospective single-blinded randomized clinical trial
Patient and methods
Patients with adhesive capsulitis were enrolled and randomly allocated into group 1 ultrasound guided hydrodilatation with steroid via posterior approach and group 2 ultrasound guided hydrodilatation with steroid via posterior approach as well as axillary nerve injection The patients were evaluated before treatment and were reevaluated 0 6 and 12 weeks after the beginning of the treatment Outcomes measures included a pain scale visual analog scale range of motion and Shoulder Pain And Disability Index
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None